Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 175-178

  Ozyuncu, Ozgur ^a   Nemutlu, Emirhan ^a   Katlan, Doruk ^a   Kir, Sedef ^a   Beksac, M Sinan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Antibiotics; Cefepime; Cefoperazone; Fetal blood; Levofloxacin; Maternal blood; Moxifloxacin

Indexed keywords

CEFEPIME; CEFOPERAZONE; CEPHALOSPORIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ARTERIAL BLOOD; ARTICLE; CLINICAL ARTICLE; DELIVERY; DRUG BLOOD LEVEL; FEMALE; FETUS; FETUS BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MATERNAL BLOOD; PLACENTAL TRANSFER; PREGNANT WOMAN; PRIORITY JOURNAL; VENOUS BLOOD;

ADULT; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CEFOPERAZONE; CEPHALOSPORINS; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MATERNAL-FETAL EXCHANGE; OFLOXACIN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUINOLINES;

EID: 77953812678     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.011     Document Type: Article

References (15)

1. Gibbs R.S. Clinical risk factors for puerperal infection. Obstet Gynecol 1980, 55(5 Suppl):178S-184S.
2. Smaill F., Hofmeyr G.J. Antibiotic prophylaxis for cesarean section. Cochrane Database Syst Rev 2002, CD000933.
3. Hopkins L., Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section. Cochrane Database Syst Rev 2000, CD001136.
4. American College of Obstetricians and Gynecologists. ACOG practice bulletin number 47, October 2003: prophylactic antibiotics in labor and delivery. Obstet Gynecol 2003;102:875-82.
5. Tita A.T., Hauth J.C., Grimes A., Owen J., Stamm A.M., Andrews W.W. Decreasing incidence of postcesarean endometritis with extended-spectrum antibiotic prophylaxis. Obstet Gynecol 2008, 111:51-56.
6. Hooper D.J. Quinolones. Principles and practice of infectious diseases 2005, 451-467. Elsevier, Philadelphia, PA. G.L. Mendell, J.E. Bennett, R. Dolin (Eds.).
7. Andes D.R., Craig W.A. Cephalosporins. Principles and practice of infectious diseases 2005, 294-307. Elsevier, Philadelphia, PA. G.L. Mendell, J.E. Bennett, R. Dolin (Eds.).
8. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk 2008, Lippincott Williams & Wilkins, Philadelphia, PA.
9. Nemutlu E., Kir S., Katlan D., Beksac M.S. Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone. Talanta 2009, 80:117-126.
10. Nemutlu E., Ki{dotless}r S., Ozyuncu O., Beksac M.S. Simultaneous separation and determination of seven quinolones using HPLC: analysis of levofloxacin and moxifloxacin in plasma and amniotic fluid. Chromatographia 2007, 66:15-24.
11. Watts D.H., Hillier S.L., Eschenbach D.A. Upper genital tract isolates at delivery as predictors of post-cesarean infections among women receiving antibiotic prophylaxis. Obstet Gynecol 1991, 77:287-292.
12. Roberts S., Maccato M., Faro S., Pinell P. The microbiology of post-cesarean wound morbidity. Obstet Gynecol 1993, 81:383-386.
13. Polachek H., Holcberg G., Sapir G., Tsadkin-Tamir M., Polachek J., Katz M., et al. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro. Eur J Obstet Gynecol Reprod Biol 2005, 122:61-65.
14. Matsuda S., Tanno M., Kashiwakura T., Furuya H. Placental transfer of cefoperazone (T-1551) and a clinical study of its use in obstetrics and gynecological infections. Curr Chemo Infect Dis 1979, 2:167-168.
15. Shimizu K. Cefoperazone: absorption, excretion, distribution, and metabolism. Clin Ther 1980, 3:60-79.